{
    "organizations": [],
    "uuid": "956ef14681b427e7e3c1f225f4879683dad560ac",
    "author": "",
    "url": "https://www.reuters.com/article/brief-corepharma-acquired-by-investor-gr/brief-corepharma-acquired-by-investor-group-idUSASB0C33N",
    "ord_in_thread": 0,
    "title": "BRIEF-Corepharma Acquired By Investor Group",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Impax Laboratories Inc:\n* COREPHARMA, LLC ACQUIRED BY INVESTOR GROUP * COREPHARMA, LLC - FINANCIAL TERMS OF ACQUISITION WERE NOT DISCLOSED\n* COREPHARMA, LLC - VITHAL DHADUK HAS BEEN APPOINTED AS PRESIDENT AND CHAIRMAN OF BOARD OF DIRECTORS OF CO\n* COREPHARMA, LLC - ‚ÄçEFFECTIVE IMMEDIATELY UPON CLOSING OF DEAL, ARPIT PATEL HAS BEEN APPOINTED AS CEO OF CO, TO ALSO BECOME MEMBER OF BOARD OF CO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T23:54:00.000+02:00",
    "crawled": "2018-01-31T00:11:39.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "impax",
        "laboratory",
        "inc",
        "corepharma",
        "llc",
        "acquired",
        "investor",
        "group",
        "corepharma",
        "llc",
        "financial",
        "term",
        "acquisition",
        "disclosed",
        "corepharma",
        "llc",
        "vithal",
        "dhaduk",
        "appointed",
        "president",
        "chairman",
        "board",
        "director",
        "co",
        "corepharma",
        "llc",
        "immediately",
        "upon",
        "closing",
        "deal",
        "arpit",
        "patel",
        "appointed",
        "ceo",
        "co",
        "also",
        "become",
        "member",
        "board",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}